Christian D. Fankhauser retweeted
My son’s Jones Beach IRONMAN was canceled this morning, so I built something I’ve wanted for a while: one place for daily urology news, events & podcasts.
Introducing UrologyWatch.com.
Tell me what works, what doesn’t, and whether it’s worth maintaining.
Introducing UrologyWatch.com.
Tell me what works, what doesn’t, and whether it’s worth maintaining.
25
17
120
11,376
New video: I changed my surgical technique this month after learning from an old case. I now always do primary bladder neck closure with an omental flap and a suprapubic catheter, in addition to the Mitrofanoff/Monti stoma catheter youtu.be/2HpYYqorjkg
0
0
6
1,178
🎥In my new job as head of dept I’m launching a youtube video channel
🏆 Europe’s first SP RPLND – Video Prize winner at @ERUSrobotics
IMHO SP offers a more favorable instrument angle + fully hidden ports below the underwear line
▶️ youtu.be/ShwGvynqsg8?is…
🏆 Europe’s first SP RPLND – Video Prize winner at @ERUSrobotics
IMHO SP offers a more favorable instrument angle + fully hidden ports below the underwear line
▶️ youtu.be/ShwGvynqsg8?is…
6
0
29
4,322
Christian D. Fankhauser retweeted
This is one of the best pieces I’ve read in a long time. Many thanks to @anish_koka for this superb piece and thoughtful recounting. Those who really know @VPrasadMDMPH know he will do even more good and rise even higher.
13
55
351
57,228
Christian D. Fankhauser retweeted
Our @JCO_ASCO commentary is out today:
“BCG and Beyond: Is Systemic Immunotherapy for BCG-Naïve NMIBC Progress or Overreach?”
Systemic IO has now entered the BCG-naïve high-risk NMIBC space. The signal is real. The interpretation must be disciplined.
Thread below. 🧵
AU26 @AndreaNecchi @BrigidaMaiorano @shilpaonc @UrogerliMD @pjhensley11 @spsutkaMD @AmirHorowitz @IBCG_BladderCA @JCO_ASCO #OncSurgery
“BCG and Beyond: Is Systemic Immunotherapy for BCG-Naïve NMIBC Progress or Overreach?”
Systemic IO has now entered the BCG-naïve high-risk NMIBC space. The signal is real. The interpretation must be disciplined.
Thread below. 🧵
AU26 @AndreaNecchi @BrigidaMaiorano @shilpaonc @UrogerliMD @pjhensley11 @spsutkaMD @AmirHorowitz @IBCG_BladderCA @JCO_ASCO #OncSurgery
5
33
70
7,414
Christian D. Fankhauser retweeted
in J Urol this month a decision analysis of PLND during RP
Take home message: benefits of PLND outweigh risk for most patients.
auajournals.org/doi/10.1097/JU…
@VickersBiostats @UrologyMSK #prostatecancer
@Uroweb @AmerUrological
Take home message: benefits of PLND outweigh risk for most patients.
auajournals.org/doi/10.1097/JU…
@VickersBiostats @UrologyMSK #prostatecancer
@Uroweb @AmerUrological
1
12
41
8,173
Christian D. Fankhauser retweeted
It's out 🚀 Our multicentric collaboration just got published in @BJUIjournal. Huge thanks to all our incredible co-authors and the @YAUpenile_tesCa who made this work possible.
Read it here: bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…
@MaartenAlbersen, @Brouwer_MD_PhD, @BE_Ayres, @CDFankhauser
Read it here: bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…
@MaartenAlbersen, @Brouwer_MD_PhD, @BE_Ayres, @CDFankhauser
0
5
10
989
Christian D. Fankhauser retweeted
New out in @TheLancetOncol with Ted Schaeffer:
pubmed.ncbi.nlm.nih.gov/41038181/
"Revisiting prostate cancer active surveillance candidacy"
A close look at the fallacy and risks of active surveillance (AS) in unselected intermediate risk (IR) men.
@wandering_gu @TylerSbrt
pubmed.ncbi.nlm.nih.gov/41038181/
"Revisiting prostate cancer active surveillance candidacy"
A close look at the fallacy and risks of active surveillance (AS) in unselected intermediate risk (IR) men.
@wandering_gu @TylerSbrt
2
19
64
4,808
Christian D. Fankhauser retweeted
Ever wondered whether elective scrotal surgery really needs perioperative antibiotic prophylaxis (PAP)? 🤔
Our new @wjurol study found a 3× lower SSI rate (12% vs 4%; p=0.058) and fewer readmissions (26% vs 16%; p=0.13) with PAP.
Although not statistically significant, PAP may still help protect selected high-risk patients from postoperative infections.
In an era of rising antimicrobial resistance, routine prophylaxis warrants careful reconsideration! 💊
🔗 Full text – rdcu.be/eIo6F
@MaximeValle5 @StanglFabian @endouro @AgostinoMattei @CDFankhauser
Our new @wjurol study found a 3× lower SSI rate (12% vs 4%; p=0.058) and fewer readmissions (26% vs 16%; p=0.13) with PAP.
Although not statistically significant, PAP may still help protect selected high-risk patients from postoperative infections.
In an era of rising antimicrobial resistance, routine prophylaxis warrants careful reconsideration! 💊
🔗 Full text – rdcu.be/eIo6F
@MaximeValle5 @StanglFabian @endouro @AgostinoMattei @CDFankhauser
1
2
4
298
Christian D. Fankhauser retweeted
Would surgery add survival benefit to the systemic treatment in patients with oligometastatic prostate cancer ? A new data highlights this;
👉Adding radical prostatectomy to best systemic therapy cut 5-yr cancer-specific mortality from 23% to 13% (HR 0.39, p=0.045). Early S benefit not statistically significant; 14% had major surgery complications.
👉Supports further efforts for local therapy + systemic treatment in oligomet prostate cancer.
doi.org/10.1016/j.euru…
@EUplatinum @OncoAlert @ONCOassist @APCCC_Lugano
👉Adding radical prostatectomy to best systemic therapy cut 5-yr cancer-specific mortality from 23% to 13% (HR 0.39, p=0.045). Early S benefit not statistically significant; 14% had major surgery complications.
👉Supports further efforts for local therapy + systemic treatment in oligomet prostate cancer.
doi.org/10.1016/j.euru…
@EUplatinum @OncoAlert @ONCOassist @APCCC_Lugano
0
46
124
11,611
Christian D. Fankhauser retweeted
Still leading the pack! @EUplatinum
European Urology remains at the top of our field in Nephrology and Urology!
With the new IF of 25.2, over 2 million website downloads, and 40.7k followers on Twitter we are constantly striving to be a cut above the rest!
Thank you to our Authors, Reviewers, and Readership!
#MedTwitter
0
2
9
1,086
Christian D. Fankhauser retweeted
@JoshMeeks provides an amazing overview of the significant data emerging in the BCG-unresponsive NMIBC space, focusing on the CIS cohorts. We also discuss the recent ODAC decision on UGN-102 for lower risk disease which was recently FDA approved.
spotifycreators-web.app.link/e/szAiuFvyaUb
spotifycreators-web.app.link/e/szAiuFvyaUb
1
29
76
14,297
Christian D. Fankhauser retweeted
It's #BladderCancerAwarenessMonth! Urologists play a key role in smoking cessation counseling. Tune in as @CDFankhauser and Dr. Richard Matulewicz @MSKCancerCenter discuss #URO54
open.spotify.com/episode/1LUfPq…
open.spotify.com/episode/1LUfPq…
0
2
8
1,531
Christian D. Fankhauser retweeted
Thanks @Cacciamani_MD 🙏
⚡️ Use AI to boost your practice! This video covers 11 immediate applications, from AI scribes to virtual assistants
Here's a bonus quote from @CanesDavid, an outstaying colleague and one of my source of inspiration.. (for real!!)
"If you're entering patient information though, use a HIPAA-compliant interface like Doximity GPT, which is free." ()
#AIinMedicine #MedicalTechnology #Efficiency #AUA2025 #ArtificialIntelligence #Healthcare #Telehealth
#PhysicianLife
youtu.be/OJLqIU2nbzc?si…
0
1
8
1,802
Christian D. Fankhauser retweeted
New results from the CREST Study (NCT04165317) for HR-NMIBC:
Adding sasanlimab to BCG induction + maintenance shows:
•32% ⬇️of EFS event (HR 0.68, p=0.0095)
•>50% reduction in HG recurrence
•No difference in overall survival (OS interim HR 1.13, p=0.6791) #AUA25 #bladdercancer
Adding sasanlimab to BCG induction + maintenance shows:
•32% ⬇️of EFS event (HR 0.68, p=0.0095)
•>50% reduction in HG recurrence
•No difference in overall survival (OS interim HR 1.13, p=0.6791) #AUA25 #bladdercancer
2
25
64
4,231
Christian D. Fankhauser retweeted
More great data from Alberta: @urethrologist present long-term urinary toxicity following various tx combinations for #prostatecancer RP seems to do the best, but none of these curves flattens over time. #aua25
2
5
21
2,267
Christian D. Fankhauser retweeted
Nobel laureate Bill Kaelin on Killing the Science Golden Goose.
"This is especially worrisome because becoming a scientist is largely taught by apprenticeship, with each generation teaching the next. We risk losing the next generation, our “seed corn”"
amjmed.com/article/S0002-…
"This is especially worrisome because becoming a scientist is largely taught by apprenticeship, with each generation teaching the next. We risk losing the next generation, our “seed corn”"
amjmed.com/article/S0002-…
9
46
160
17,068
Great topic and speaker
❓ Role of SBRT-only in hormone-sensitive oligometastatic prostate cancer
❓ Value of 6-months ADT added to SBRT
❓ Appropriate endpoints
Virtual Grand Rounds in Radiation Oncology
usz.ch/en/events/virt…
Proudly presenting: @BarbaraJereczek
Wed April 2nd 17:00 – 17:30 CET 👇
1
0
4
619
Christian D. Fankhauser retweeted
Tired of the noise on @X? Join our @telegram channel w/all the key European Urology Network updates and important #urology pubs in one place. No Elon musk tweets or ads just pubs and your own community. Subscribe info below 👇 @Uroweb @AmerUrological #AcademicResearch
0
3
18
1,970